论文部分内容阅读
我们在1996～1999年间采用肝活素治疗慢性乙型肝炎,并与使用安慰剂的对照组进行比较。主要观察肝活素对慢性乙型肝炎病人的疗效和安全性。 1 研究方法 1.1 试验设计 采用随机双盲,安慰剂对照的试验方法。 1.2 病例选择 246例初筛通过,46例不接受试验治疗,实际进入试验200例。入选标准为年龄16～65岁,筛选前HBsAg阳性至少6个月或6个月以上,筛选前3个月内血清ALT在
We treated chronic hepatitis B with hepcidin between 1996 and 1999 and compared it to placebo-treated controls. The main observation of hepatic activity in patients with chronic hepatitis B efficacy and safety. A study 1.1 trial design randomized double-blind, placebo-controlled test method. 1.2 cases of 246 cases of primary screening through, 46 cases did not receive the experimental treatment, the actual entry into the trial of 200 cases. Inclusion criteria for age 16 to 65 years old, screening positive for HBsAg at least 6 months or 6 months before screening serum ALT within 3 months